Search

Displaying results 3501 - 3510 of 5924 in total
  1. Drug

    Ioglucol

    go.drugbank.com/drugs/DB21450
    Experimental

    Ioglucol has a monoisotopic molecular weight of 806.86 Da.

  2. Drug

    Sulfasymazine

    go.drugbank.com/drugs/DB21451
    Experimental

    Sulfasymazine has a monoisotopic molecular weight of 307.11 Da.

  3. Drug

    Ervogastat

    go.drugbank.com/drugs/DB21489
    Experimental

    Ervogastat has a monoisotopic molecular weight of 407.16 Da.

  4. Drug

    Amelenodor

    go.drugbank.com/drugs/DB21563
    Experimental

    Amelenodor has a monoisotopic molecular weight of 399.16 Da.

  5. Drug

    Vulolisib

    go.drugbank.com/drugs/DB21567
    Experimental

    Vulolisib has a monoisotopic molecular weight of 423.12 Da.

  6. Drug

    Teprosulvose

    go.drugbank.com/drugs/DB21738
    Experimental

    Teprosulvose has a monoisotopic molecular weight of 568.33 Da.

  7. Drug

    Suvadronabinol

    go.drugbank.com/drugs/DB21741
    Experimental

    Suvadronabinol has a monoisotopic molecular weight of 513.31 Da.

  8. Drug

    Loncastuximab tesirine

    go.drugbank.com/drugs/DB16222
    ApprovedInvestigational

    Zylonta also received approval in the EU on December 22, 2022.

    Categories: P-glycoprotein substrates, Cytochrome P-450 Substrates
  9. Drug

    Bufexamac

    go.drugbank.com/drugs/DB13346
    ApprovedWithdrawn

    The use of bufexamac has been discontinued in Canada and the United States, which may be due to undetermined clinical efficacy and a high prevalence of contact sensitization [A32822].

    Synonyms: 2-(p-Butoxyphenyl)-acetohydroxamic acid, p-Butoxyphenylacetohydroxamic acid
  10. Drug

    Etretinate

    go.drugbank.com/drugs/DB00926
    ApprovedWithdrawn

    Etretinate was taken off the market in Canada in 1996 and America in 1998 due to the risk of birth defects. Etretinate is now used to treat T-cell lymphomas.